Trials indicate that Vectibix more effective in treating colon cancer in combination with chemotherapy
스크롤 이동 상태바
Trials indicate that Vectibix more effective in treating colon cancer in combination with chemotherapy
기자명
메디칼라이터팀
입력 2009.08.10 00:00
수정 2009.08.10 10:09
댓글 0
1,183 patients with colon cancer were compared while on either a combination of the Amgen Inc. drug, Vectibix [panitumumab] and a chemotherapy regimen, called Folfox, to chemotherapy alone in the late stage trial. The company said that the Vectibix group had greater progression-free survival, a measurement of how long they lived until their disease began to advance or spread again. The drug is currently approved as a third line treatment.